Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Masatoshi Murakami

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8791-0052; OpenAlex author ID A5055666054. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-025-03633-4↗
  3. Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2024.108958↗
  4. Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Co-author DOI 10.1007/s00535-024-02103-0↗
  5. Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship with the prognosis Co-author DOI 10.21203/rs.3.rs-4088010/v1↗
  6. Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-023-05591-2↗
  7. Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1007/s12672-021-00462-1↗
  8. Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. Co-author DOI 10.1186/s12885-022-10207-0↗
  9. Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic… Co-author DOI 10.3390/jcm11175084↗
  10. Colonic varices: a rare complication of pancreatic cancer. Co-author DOI 10.1007/s12328-020-01225-1↗
  11. [Massive biliary hemorrhage due to rupture of pseudoaneurysm after endoscopic biliary plastic stenting for pancreatic cancer]. Co-author DOI 10.11405/nisshoshi.116.754↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nao Fujimori · 9 shared papers, 2020–2026 · strength 1.54
  2. Yoshihiro Ogawa · 8 shared papers, 2020–2026 · strength 1.38
  3. Katsuhito Teramatsu · 6 shared papers, 2020–2026 · strength 1.01
  4. Kazuhide Matsumoto · 6 shared papers, 2020–2026 · strength 1.01
  5. Akihisa Ohno · 5 shared papers, 2022–2026 · strength 0.90
  6. Kohei Nakata · 5 shared papers, 2022–2025 · strength 0.83
  7. Kousei Ishigami · 3 shared papers, 2022–2025 · strength 0.52
  8. Toshiya Abe · 3 shared papers, 2022–2025 · strength 0.52
  9. Noboru Ideno · 3 shared papers, 2022–2025 · strength 0.52
  10. Naoki Ikenaga · 3 shared papers, 2022–2025 · strength 0.52
  11. Masafumi Nakamura · 3 shared papers, 2022–2023 · strength 0.43
  12. Yoshinao Oda · 2 shared papers, 2024–2026 · strength 0.41
  13. Nobuhiro Fujita · 2 shared papers, 2023–2025 · strength 0.39
  14. Yusuke Watanabe · 1 shared paper, 2025 · strength 0.23
  15. Masafumi Nakamura · 1 shared paper, 2025 · strength 0.23
  16. Takehiro Takaoka · 1 shared paper, 2024 · strength 0.22
  17. Masafumi Nakamura · 1 shared paper, 2024 · strength 0.17
  18. Yoshinao Oda · 1 shared paper, 2023 · strength 0.16
  19. Masataka Hayashi · 1 shared paper, 2023 · strength 0.16
  20. So Nakamura · 1 shared paper, 2023 · strength 0.16
  21. Shingo Baba · 1 shared paper, 2023 · strength 0.16
  22. Masayuki Furukawa · 1 shared paper, 2022 · strength 0.14
  23. Masami Miki · 1 shared paper, 2022 · strength 0.14
  24. Lingaku Lee · 1 shared paper, 2022 · strength 0.14
  25. Koki Oyama · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.